Merger Notification - Announcement according to § 10 Cartel Act
Organon International GmbH; Eli Lilly Export S.A.
BWB/Z-6454
On 21.12.2023 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Organon International GmbH (Switzerland) entered into a distribution and promotion agreement with Eli Lilly Export S.A. (Switzerland), pursuant to which Organon International GmbH will be appointed as
the sole distributor of Eli Lilly and Company’s two anti-migraine pharmaceuticals in the EU and certain additional countries in Europe. The notification is submitted on a precautionary basis.
The distribution and promotion agreement concerns the distribution of pharmaceuticals.
Industry sector: G - Handel; Instandhaltung und Reparatur von Kraftfahrzeugen
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 18.01.2024.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 19.01.2024 .